CROs Archives ⋆ Vial

Updates in the Ophthalmology Clinical Landscape

The field of ophthalmology is dedicated to preserving and restoring vision, recognizing its significance to human well-being. Yet, hereditary and age-related retinal diseases present challenges, often leading to progressive vision loss and potential blindness. Among these conditions, age-related macular degeneration (AMD) and diabetic retinopathy are of particular concern, with the global patient population expected to […]

Updates in the Ophthalmology Clinical Landscape Read More »

Group of doctors sitting at a table talking.

IQVIA vs Vial | Pros and Cons

Leave a Comment / Articles / Owen Allen

The increasing costs associated with in-house drug development have prompted biotech and pharmaceutical companies to increasingly outsource to contract research organizations (CROs) for assistance. CROs like Vial, IQVIA, PPD, ICON, among others, have distinguished themselves through strategic partnerships and innovative products and services, positioning them as leaders in the industry. However, one size does not

IQVIA vs Vial | Pros and Cons Read More »

The Costs of Working with a CRO

Leave a Comment / Articles / Owen Allen

The Costs of Working with a CRO Running clinical trials is an integral part of the pharmaceutical industry, crucial to the development and approval of new drugs and treatments. However, because these trials come with a significant financial burden, sponsor companies are constantly seeking ways to optimize their operations. Traditionally, they can go about this

The Costs of Working with a CRO Read More »

Worldwide Clinical Trials vs Vial | Pros and Cons

Leave a Comment / Articles / Owen Allen

Introduction Worldwide Clinical Trials vs. Vial. How do they stack up? Worldwide Clinical Trials is a mid-size, full-service global contract research organization (CRO) that works with biotech and pharma to advance new medications. With an international presence in nearly 60 countries, Worldwide is supported by over 3,400 team members. Vial is a tech-first CRO reimagining

Worldwide Clinical Trials vs Vial | Pros and Cons Read More »

First in Human Episode #56 featuring Jason Bock

What is the largest CRO in the US?

Leave a Comment / Articles / Owen Allen

Introduction Contract research organizations (CROs) are essential in pharmaceutical research and development (R&D). By geographical region, the global CRO services market in 2023 was dominated by North America. Growth factors for this market included the growing size of the pharmaceutical industry, the increasing number of clinical trials, substantial funds dedicated to pharma and biotech R&D,

What is the largest CRO in the US? Read More »

PPD vs. Vial | Pros and Cons

Leave a Comment / Articles / Owen Allen

The pharmaceutical and biotechnological landscape is constantly evolving and a key partner within the drug development process is contract research organizations (CROs), who are at the forefront with sponsors to drive innovation in clinical research. A CRO is an organization that offers specialized services to clinical trial companies, whether pharmaceutical, biotechnology, and medical device, accelerating

PPD vs. Vial | Pros and Cons Read More »

The Evolution of Digital Patient Portals: Enhancing Healthcare Access and Engagement

Leave a Comment / Articles / Owen Allen

In 2022, the global market value of patient portals within the clinical research and healthcare industries was estimated to be US $2.9 billion and is expected to climb at a compound annual growth rate (CAGR) of 19.44% between 2023 and 2030. A number of factors are contributing to this increase in popularity of digital patient

The Evolution of Digital Patient Portals: Enhancing Healthcare Access and Engagement Read More »

A white background with a prominent DNA helix, symbolizing the intersection of medical advancements and biotechnology in genetic research.

Top 7 Gene Therapy CROs

Leave a Comment / Articles / Owen Allen

With the rising incidence of cancer and neurological disorders, many of which have historically been considered untreatable, gene therapy and technological advances are working to rapidly change these therapeutic landscapes. As of 2022, the global market for gene therapy clinical research was valued at US$7.54 billion, with a compound annual growth rate (CAGR) of 19.1%

CROs

Updates in the Ophthalmology Clinical Landscape

IQVIA vs Vial | Pros and Cons

The Costs of Working with a CRO

Worldwide Clinical Trials vs Vial | Pros and Cons

First in Human Episode #56 featuring Jason Bock

What is the largest CRO in the US?

PPD vs. Vial | Pros and Cons

The Evolution of Digital Patient Portals: Enhancing Healthcare Access and Engagement

Top 7 Gene Therapy CROs

CRO

Resources

Company

Sign up for Newsletter